Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-29
2000-10-10
Harrison, Robert H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548574, A61K 3300
Patent
active
061302422
ABSTRACT:
A method for treating urinary incontinence, such as incontinence resulting from bladder detrusor muscle instability, using enantiomerically enriched (S)-procyclidine. The method comprises administering a therapeutically effective amount of enantiomerically enriched (S)-procyclidine, or a pharmaceutically acceptable salt thereof, substantially free of the (R)-procyclidine enantiomer. Pharmaceutical compositions for the treatment of urinary incontinence comprising enantiomerically enriched (S)-procyclidine, or a pharmaceutically acceptable salt thereof, and an acceptable carrier are also disclosed.
REFERENCES:
patent: 5532278 (1996-07-01), Aberg et al.
patent: 5616580 (1997-04-01), Olney
patent: 5677346 (1997-10-01), Aberg et al.
patent: 5736577 (1998-04-01), Aberg et al.
patent: 5939426 (1999-08-01), McCullough
patent: 5994369 (1999-11-01), Kolassa et al.
HCAPLUS abstract, AN 1996: 716304, Kolassa et al., abstract of WO 9631208.
Goodman Gilman et al., The Pharmacological Basis of Therapeutics (6th Ed.), New York: MacMillan, p. 120, 1980.
Waelbroeck et al., "Stereoselective interaction of procyclidine, hexahydro-difenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptors," European Journal of Pharmacology--Molecular Pharmacology Section, 227:33-42 (1992).
Waelbroeck et al., "Thermodynamics of antogonist binding to rat muscarinic M.sub.2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type," Br. J. Pharmacol., 109:360-370 (1993).
Barlow, R.B., "Differences in the stereospecificity of closely related compounds; a reinvestigation of the enantiomers of procyelidine, benzhexol and their metho- and etho-salts", J. Pharm. Pharmac., 23:90-97 (1971).
Waelbroeck et al., "Stereoselectivity of procyclidine binding to muscarinic receptor subtypes M.sub.1,M.sub.2 and M.sub.4, " European Journal of Pharmacology--Molecular Pharmacology Section, 189:135-142 (1990).
Noronha-Blob, L. and Kachur, J.F., "Enantiomers of Oxybutynin: In Vitro Pharmacological Characterization at M.sub.1, M.sub.2 and M.sub.3 Muscarinic Receptors and in Vivo Effects in Urinary Bladder Contraction, Mydriasis and Salivary Secretion of Guinea Pigs," The Journal of Pharmacology and Experimental Therapeutics, 256:562-567 (1991).
Barlow et al., "A Comparison of Stereospecificity at Central and Peripheral `Muscarine-Sensitive` Acetylcholine Receptors: Observations with the Enantiomeric Forms of Procyclidine and Tricyclamol," Br. J. Pharmac, 72:277-280 (1981).
Junemann, K.P. and Melchior, H., "Blasenfunktionsstorungen bei Parkinson-Syndrom," Urologe, 29:170-175 (1990).
Murphy, Leonard J.T., "Urological prolems in aged patients," Australian Family Physician, 6:17-28 (1997).
Alberts, Peteris, "Classification of the Presynaptic Muscarinic Receptor Subtype that Regulates .sup.3 H-Acetylcholine Secretion in the Guinea Pig Urinary Bladder in Vitro," The Journal of Pharmacology and Experimental Therapeutics, 274:458-468 (1995).
Ariens, E.J., "Stereoselectivity in pharmacodynamics and pharmacokinetics," Schweiz. med. Wschr., 120:131-134 (1990).
Fabiano Vincent L.
McCullough John R.
Harrison Robert H.
Sepracor Inc.
LandOfFree
S-procyclidine for treating urinary incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with S-procyclidine for treating urinary incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S-procyclidine for treating urinary incontinence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2257327